None listed
Conditions
Brief summary
Patients undergoing rehabilitation due to neurological diseases such as stroke, Parkinson’s disease, traumatic brain injury and spinal cord injury are often faced with significant physical and psychological stressors. Patients are often inattentive and not motivated during therapy sessions. Music therapy (MT), which is the clinical use of music interventions within a therapeutic relationship, has been shown to be of benefit to patients with neurological diseases in rehabilitation setting. The data on mood, attention and motivation level of patients undergoing rehabilitation in the neurology rehabilitation ward is, however, limited especially where music therapist is involved. Hence this pilot study aims to investigate the effectiveness of rhythmic stimulation on upper limb function and mood of stroke patients with undergoing rehabilitation in the inpatient neurology rehabilitation ward. The study design is a randomized controlled trial of 26 patients receiving standard rehabilitation together with MT intervention who will be compared with 26 patients receiving only standard rehabilitation as usual. The null hypotheses being tested are that there will be no significant differences in upper limb function, mood and participation level in ARAT, HADS, visual analog mood scale (Faces Scale, Andrews & Withey, 1976), and PRPS between the two groups of patients. The inclusion criteria for participation in the study include persons diagnosed either with ischaemic or haemorrhagic acute stroke undergoing daily occupation therapy for 10 sessions (exclude weekends and public holidays). Each standard occupational therapy session will last for up to 60 minutes, out of which up to 30 minutes will be focused on upper limb rehabilitation. The music therapy intervention will have up to 30 minutes therapy session and is provided daily by a board certified music therapist for a duration of 10 sessions (exclude weekends and public holidays). The components of the intervention include music rhythmic stimulation with movement exercises directed by occupational therapist.
Interventions
The study design is a randomized controlled trial of 26 patients receiving standard rehabilitation together with Music Therapy intervention who will be compared with 26 patients receiving only standard rehabilitation as usual. Each standard occupational therapy session will last for up to 60 minutes, out of which up to 30 minutes will be focused on upper limb rehabilitation. The music therapy intervention will have up to 30 minutes therapy session and is provided daily by a board certified music therapist for a duration of 10 sessions (exclude weekends and public holidays). The components of the intervention include music rhythmic stimulation with movement exercises directed by occupational therapis simultaneously. The exercise is sequential flexion-extension of elbow movements of one arm. All subjects in the study will received individualised therapy. All subjects in either condition will receive up to 60-minute intervention daily for a duration of 10 sessions (exclude weekends and public holidays). The follow-up will be 3 weeks.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with stroke, who is at least 21 years of age or above and admitted to SGH Department of Rehabilitation Medicine between the period of November 2012 - October 2013. - Acquired brain injury, that is, stroke - First stroke patient referred for occupational therapy - MMSE greater or equal to 18 (Levels of impairment have also been classified as none (24-30); mild (18-23) and severe (0-17) (Tombaugh & McIntyre 1992) - Upper limb impairment Manual Muscle Testing (MMT) = 1, 2 or 3 - Medically stable to participate in an active rehabilitation program
Exclusion criteria
Exclusion criteria: * Individuals will be excluded if they have any other acute co-morbidities influencing their mobility, that is: - Patients with pre-existing upper limb impairments eg. Amputation, deformity, contracture - Patients with Parkinson's Disease - Patients with severe spasticity (MAS greater than or equal to 2) - Patients with severe hearing impairment * Patients recruited in other study